Tasneem M Poonawala

US Patent:

8425454, Apr 23, 2013

Filed:

Jun 28, 2010

Appl. No.:

12/825174

Inventors:

Allan C. Shuros - St. Paul MN, US
M. Jason Brooke - Woodstock MD, US
Tasneem Poonawala - Eagan MN, US

Assignee:

Cardiac Pacemakers, Inc. - St. Paul MN

International Classification:

A61M 29/00

US Classification:

604 9601

Abstract:

Renal function may be modulated by an implantable device having one or more leads or catheters disposed near the kidney via the lymphatic system. In one embodiment, lymphatic drainage from the kidney is modulated to increase or decrease tubular reabsorption of salt and water. The renal function modulation therapy may be delivered in an open-loop or closed-loop fashion, with the latter dependent upon a physiological variable such as blood pressure or cardiac output.

US Patent:

20080140000, Jun 12, 2008

Filed:

Dec 7, 2006

Appl. No.:

11/567907

Inventors:

Allan C. Shuros - St. Paul MN, US
M. Jason Brooke - Minneapolis MN, US
Tasneem Poonawala - Eagan MN, US

Assignee:

CARDIAC PACEMAKERS, INC. - ST. PAUL MN

International Classification:

A61M 29/00
A61N 1/00

US Classification:

604 9601, 606192, 607 2

Abstract:

Renal function may be modulated by an implantable device having one or more leads or catheters disposed near the kidney via the lymphatic system. In one embodiment, lymphatic drainage from the kidney is modulated to increase or decrease tubular reabsorption of salt and water. The renal function modulation therapy may be delivered in an open-loop or closed-loop fashion, with the latter dependent upon a physiological variable such as blood pressure or cardiac output.

US Patent:

20130237954, Sep 12, 2013

Filed:

Apr 22, 2013

Appl. No.:

13/867552

Inventors:

M. Jason Brooke - Woodstock MD, US
Tasneem Poonawala - Eagan MN, US

Assignee:

Cardiac Pacemakers, Inc. - St. Paul MN

International Classification:

A61N 1/36
A61M 25/00

US Classification:

604500, 604264, 607 72

Abstract:

Renal function may be modulated by an implantable device having one or more leads or catheters disposed near the kidney via the lymphatic system. In one embodiment, lymphatic drainage from the kidney is modulated to increase or decrease tubular reabsorption of salt and water. The renal function modulation therapy may be delivered in an open-loop or closed-loop fashion, with the latter dependent upon a physiological variable such as blood pressure or cardiac output.